MTD Group’s DropSafe Sicura Passive Safety Needle Gains FDA Nod

MTD Group has earned U.S. Food and Drug Administration (FDA) clearance for its DropSafe Sicura passive safety needle for intramuscular and subcutaneous injection of vaccines and other medicines.
 
Safety needles are used to avoid the risk of needlestick injuries. Despite more safety regulations over the past decades, it’s estimated over two million needlestick injuries still occur each year¹.
 
“Moving towards safer medical device technology –and especially evolving sharps with injury prevention features to a more passive design– promises to reduce needlestick injuries. Safety device designs that require a user to actively do something can result in injury during activation, or failure to activate the safety feature at all. Truly passive designs can not only protect the user, but those downstream who may encounter that contaminated device as well,” Amber Mitchell, DrPH, MPH, CPH, president and executive director of the International Safety Center told the press.
 
DropSafe Sicura is protected by a transparent shield that automatically locks following injection, needing no incremental activation step post-injection.
 
“Since the COVID pandemic began, vaccination effectiveness is a key global focus. A fully passive injection device such as the DropSafe Sicura, fulfills an unmet need of our customers in the US for increased safety. We will immediately start to make the product available to pharmacy chains and the other practices that are fully focused in delivering care throughout the U.S.,” concluded Carl Ward, GM of HTL Inc., the MTD Group company in North America.
 
Reference
¹ Bouya S, Balouchi A et al. Global Prevalence and Device Related Causes of Needle Stick Injuries among Health Care Workers: A Systematic Review and Meta-Analysis.2020;86(1):35